Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
ATRX mutation
i
Other names:
ATRX, ATRX Chromatin Remodeler, Transcriptional Regulator ATRX, ATP-Dependent Helicase ATRX, X-Linked Nuclear Protein, X-Linked Helicase II, XH2, XNP, Alpha Thalassemia/Mental Retardation Syndrome X-Linked (RAD54 (S. Cerevisiae) Homolog), Alpha Thalassemia/Mental Retardation Syndrome X-Linked (RAD54 Homolog S. Cerevisiae), Alpha Thalassemia/Mental Retardation Syndrome X-Linked, Mental Retardation X-Linked 52, RAD54 Homolog (S. Cerevisiae), Juberg-Marsidi Syndrome, ZNF-HX, Znf-HX, MRX52, JMS
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
546
Related biomarkers:
Mutation
CNA
Others
‹
ATRX deletion (3)
ATRX deletion (3)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
ATRX mutation
Prostate Cancer
ATRX mutation
Prostate Cancer
olaparib
Sensitive: C2 – Inclusion Criteria
olaparib
Sensitive
:
C2
olaparib
Sensitive: C2 – Inclusion Criteria
olaparib
Sensitive
:
C2
ATRX mutation
Gastroesophageal Junction Adenocarcinoma
ATRX mutation
Gastroesophageal Junction Adenocarcinoma
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
ATRX mutation
Gastric Adenocarcinoma
ATRX mutation
Gastric Adenocarcinoma
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
ATRX mutation
Leiomyosarcoma
ATRX mutation
Leiomyosarcoma
eribulin mesylate
Resistant: C3 – Early Trials
eribulin mesylate
Resistant
:
C3
eribulin mesylate
Resistant: C3 – Early Trials
eribulin mesylate
Resistant
:
C3
ATRX mutation
Leiomyosarcoma
ATRX mutation
Leiomyosarcoma
dacarbazine
Resistant: C3 – Early Trials
dacarbazine
Resistant
:
C3
dacarbazine
Resistant: C3 – Early Trials
dacarbazine
Resistant
:
C3
ATRX mutation
Triple Negative Breast Cancer
ATRX mutation
Triple Negative Breast Cancer
olaparib
Sensitive: C3 – Early Trials
olaparib
Sensitive
:
C3
olaparib
Sensitive: C3 – Early Trials
olaparib
Sensitive
:
C3
ATRX mutation
Gastric Cancer
ATRX mutation
Gastric Cancer
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
ATRX mutation
Neuroblastoma
ATRX mutation
Neuroblastoma
AZD1775
Sensitive: C3 – Early Trials
AZD1775
Sensitive
:
C3
AZD1775
Sensitive: C3 – Early Trials
AZD1775
Sensitive
:
C3
ATRX mutation
Glioblastoma
ATRX mutation
Glioblastoma
selumetinib
Sensitive: D – Preclinical
selumetinib
Sensitive
:
D
selumetinib
Sensitive: D – Preclinical
selumetinib
Sensitive
:
D
ATRX mutation
Uterine Leiomyosarcoma
ATRX mutation
Uterine Leiomyosarcoma
BAY 1895344
Sensitive: D – Preclinical
BAY 1895344
Sensitive
:
D
BAY 1895344
Sensitive: D – Preclinical
BAY 1895344
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.